Want to see IMVT full AI Analyst Report?
Immunovant (IMVT) Ownership Overview
56.08% Insiders
11.94% Mutual Funds
2.34% Other Institutional Investors
8.02% ETFs
21.62% Public Companies and
Individual Investors
The ownership structure of Immunovant (IMVT) stock is a mix of institutional, retail, and individual investors. Approximately 22.30% of the company’s stock is owned by Institutional Investors, 56.08% is owned by Insiders, and 21.62% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 23, 2026 | xxxxxxxxxxxxx | $75099 | |
Sep 25, 2026 | xxxxxxxxxxxxx | $103481 | |
Aug 21, 2026 | xxxxxxxxxxxxx | $134953 | |
Jul 24, 2026 | xxxxxxxxxxxxx | $263015 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $52299967 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $209419027 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $223666650 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $5574174 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 113,317,007 | Insider | 54.86% | 3,192,140,087 | |
| 8,162,515 | Institution | 3.95% | 229,938,048 | |
| 7,635,408 | Institution | 3.70% | 215,089,443 | |
| 6,391,633 | Institution | 3.09% | 180,052,302 | |
| 5,805,000 | Institution | 2.81% | 163,526,850 | |
| 5,435,220 | Institution | 2.63% | 153,110,147 | |
| 4,266,514 | Institution | 2.07% | 120,187,699 | |
| 2,563,045 | Institution | 1.24% | 72,200,978 | |
| 1,975,869 | Institution | 0.96% | 55,660,230 | |
| 1,497,019 | Institution | 0.72% | 42,171,025 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,635,408 | Institution | 3.70% | 215,089,443 | |
| 6,391,633 | Institution | 3.09% | 180,052,302 | |
| 1,497,019 | Institution | 0.72% | 42,171,025 | |
| 1,339,901 | Institution | 0.65% | 37,745,011 | |
| 1,045,306 | Institution | 0.51% | 29,446,270 | |
| 879,595 | Institution | 0.43% | 24,778,191 | |
| 841,065 | Institution | 0.41% | 23,692,801 | |
| 836,754 | Institution | 0.41% | 23,571,360 | |
| 417,364 | Institution | 0.20% | 11,757,144 | |
| 412,860 | Institution | 0.20% | 11,630,266 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,016,331 | Institution | 1.46% | 101,891,661 | |
| 2,236,112 | Institution | 1.08% | 63,527,942 | |
| 2,184,323 | Institution | 1.06% | 61,532,379 | |
| 2,093,393 | Institution | 1.01% | 70,714,816 | |
| 1,165,248 | Institution | 0.56% | 39,362,077 | |
| 904,224 | Institution | 0.44% | 30,544,687 | |
| 807,365 | Institution | 0.39% | 22,743,472 | |
| 642,899 | Institution | 0.31% | 18,110,465 | |
| 502,653 | Institution | 0.24% | 16,979,618 | |
| 424,475 | Institution | 0.21% | 12,059,335 |
FAQ
Who Owns Immunovant (IMVT)?
According to the latest TipRanks data, approximately 2.34% of the company's stock is held by institutional investors, 56.08% is held by insiders, and 21.62% is held by retail investors.
What percentage of Immunovant (IMVT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.34% of Immunovant (IMVT) stock is held by institutional investors.
What percentage of Immunovant (IMVT) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.62% of Immunovant (IMVT) stock is held by retail investors.
Who owns the most shares of Immunovant (IMVT)?
Roivant Sciences Ltd. owns the most shares of Immunovant (IMVT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.